Ocular Therapeutix, Inc. (OCUL) KPIs & Operating Metrics

Ocular Therapeutix, Inc. (OCUL) key performance indicators and operating metrics (1 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.

KPIs — source: SEC EDGAR, earnings calls, investor decks
MetricLatest ValuePeriod
Dextenza End-User Unit Sales Growth9.70 percentFY2025-Q3

Back to OCUL overview · OCUL earnings · OCUL holders

Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.